Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.

Saved in:
Bibliographic Details
Title: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Authors: Shinn E; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. eshinn@mdanderson.org., Zahrieh D; Mayo Clinic, Rochester, MN, USA., DeMichele A; ECOG, University of Pennsylvania, Philadelphia, PA, USA., Zdenkowski N; The University of Newcastle, Callaghan, NSW, Australia., Lemieux J; Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Canada., Mao J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bjelic-Radisic V; Helios University Clinic Wuppertal, University Witten/Herdecke Germany, Wuppertal, Germany.; Medical University of Graz, Graz, Austria., Naughton MJ; Ohio State University/Alliance, Columbus, OH, USA., Pfeiler G; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Gelmon K; University of British Columbia, Vancouver, BC, Canada., Balko JM; Vanderbilt University Medical Center, Nashville, TN, USA., Egle D; Medical University of Innsbruck, Innsbruck, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Zoppoli G; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Policlinico San Martino IRCCS, University of Genoa, Genoa, Italy., Traina T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jimenez MM; GEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Novoa SA; A Coruña University Hospital, A Coruna, Spain., Haddad T; Mayo Clinic, Rochester, MN, USA., Chan A; Breast Cancer Research Centre, Nedlands, WA, Australia., Ring A; The Royal Marsden Hospital, NHS Foundation Trust, East Sussex, UK., Wolff A; Johns Hopkins University/ECOG, Baltimore, MD, USA., Symmans WF; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ponce Lorenzo J; GEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.; Oncology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Sabanathan D; Lakeside Specialist Breast Clinic, Nepean Cancer Care Centre, Norwest, NSW, Australia., Burstein HJ; Dana-Farber Cancer Institute, Boston, MA, USA., Nowecki ZI; The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Pristauz-Telsnigg G; Medical University of Graz, Graz, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Brufsky A; University of Pittsburgh Cancer Institute UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Bellet-Ezquerra M; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Foukakis T; Karolinska Institute and University Hospital, Solna, Sweden., Novik Y; New York University, New York, NY, USA., Rubovszky G; National Institute of Oncology, Budapest, Hungary., Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Muehlbacher K; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Filho OM; Dana-Farber Cancer Institute, Boston, MA, USA., Goulioti T; Breast International Group, Brussels, Belgium., Law E; Pfizer, Chicago, IL, USA., Partridge AH; Dana-Farber Cancer Institute, Boston, MA, USA., Carey LA; University of North Carolina/Alliance, Chapel Hill, NC, USA., Zoroufy A; Mayo Clinic, Rochester, MN, USA., Hlauschek D; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Fesl C; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA., Gnant M; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.; Medical University of Vienna AT, Vienna, Austria.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (2), pp. 385-397. Date of Electronic Publication: 2025 Mar 27.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40140172
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shinn+E%22">Shinn E</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. eshinn@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Zahrieh+D%22">Zahrieh D</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22DeMichele+A%22">DeMichele A</searchLink>; ECOG, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zdenkowski+N%22">Zdenkowski N</searchLink>; The University of Newcastle, Callaghan, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lemieux+J%22">Lemieux J</searchLink>; Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Mao+J%22">Mao J</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bjelic-Radisic+V%22">Bjelic-Radisic V</searchLink>; Helios University Clinic Wuppertal, University Witten/Herdecke Germany, Wuppertal, Germany.; Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Naughton+MJ%22">Naughton MJ</searchLink>; Ohio State University/Alliance, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Pfeiler+G%22">Pfeiler G</searchLink>; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Gelmon+K%22">Gelmon K</searchLink>; University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Balko+JM%22">Balko JM</searchLink>; Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Egle+D%22">Egle D</searchLink>; Medical University of Innsbruck, Innsbruck, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Zoppoli+G%22">Zoppoli G</searchLink>; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Policlinico San Martino IRCCS, University of Genoa, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Traina+T%22">Traina T</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jimenez+MM%22">Jimenez MM</searchLink>; GEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Novoa+SA%22">Novoa SA</searchLink>; A Coruña University Hospital, A Coruna, Spain.<br /><searchLink fieldCode="AU" term="%22Haddad+T%22">Haddad T</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Chan+A%22">Chan A</searchLink>; Breast Cancer Research Centre, Nedlands, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Ring+A%22">Ring A</searchLink>; The Royal Marsden Hospital, NHS Foundation Trust, East Sussex, UK.<br /><searchLink fieldCode="AU" term="%22Wolff+A%22">Wolff A</searchLink>; Johns Hopkins University/ECOG, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ponce+Lorenzo+J%22">Ponce Lorenzo J</searchLink>; GEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.; Oncology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.<br /><searchLink fieldCode="AU" term="%22Sabanathan+D%22">Sabanathan D</searchLink>; Lakeside Specialist Breast Clinic, Nepean Cancer Care Centre, Norwest, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Burstein+HJ%22">Burstein HJ</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nowecki+ZI%22">Nowecki ZI</searchLink>; The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Pristauz-Telsnigg+G%22">Pristauz-Telsnigg G</searchLink>; Medical University of Graz, Graz, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Brufsky+A%22">Brufsky A</searchLink>; University of Pittsburgh Cancer Institute UPMC Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bellet-Ezquerra+M%22">Bellet-Ezquerra M</searchLink>; Vall d'Hebron Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Foukakis+T%22">Foukakis T</searchLink>; Karolinska Institute and University Hospital, Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Novik+Y%22">Novik Y</searchLink>; New York University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rubovszky+G%22">Rubovszky G</searchLink>; National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Singer+CF%22">Singer CF</searchLink>; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Muehlbacher+K%22">Muehlbacher K</searchLink>; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Filho+OM%22">Filho OM</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Goulioti+T%22">Goulioti T</searchLink>; Breast International Group, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Law+E%22">Law E</searchLink>; Pfizer, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Partridge+AH%22">Partridge AH</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Carey+LA%22">Carey LA</searchLink>; University of North Carolina/Alliance, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Zoroufy+A%22">Zoroufy A</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Hlauschek+D%22">Hlauschek D</searchLink>; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Fesl+C%22">Fesl C</searchLink>; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Mayer+EL%22">Mayer EL</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gnant+M%22">Gnant M</searchLink>; Austrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.; Medical University of Vienna AT, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Jun; Vol. 211 (2), pp. 385-397. <i>Date of Electronic Publication: </i>2025 Mar 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40140172
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-025-07653-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 385
    Titles:
      – TitleFull: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shinn E
      – PersonEntity:
          Name:
            NameFull: Zahrieh D
      – PersonEntity:
          Name:
            NameFull: DeMichele A
      – PersonEntity:
          Name:
            NameFull: Zdenkowski N
      – PersonEntity:
          Name:
            NameFull: Lemieux J
      – PersonEntity:
          Name:
            NameFull: Mao J
      – PersonEntity:
          Name:
            NameFull: Bjelic-Radisic V
      – PersonEntity:
          Name:
            NameFull: Naughton MJ
      – PersonEntity:
          Name:
            NameFull: Pfeiler G
      – PersonEntity:
          Name:
            NameFull: Gelmon K
      – PersonEntity:
          Name:
            NameFull: Balko JM
      – PersonEntity:
          Name:
            NameFull: Egle D
      – PersonEntity:
          Name:
            NameFull: Zoppoli G
      – PersonEntity:
          Name:
            NameFull: Traina T
      – PersonEntity:
          Name:
            NameFull: Jimenez MM
      – PersonEntity:
          Name:
            NameFull: Novoa SA
      – PersonEntity:
          Name:
            NameFull: Haddad T
      – PersonEntity:
          Name:
            NameFull: Chan A
      – PersonEntity:
          Name:
            NameFull: Ring A
      – PersonEntity:
          Name:
            NameFull: Wolff A
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Ponce Lorenzo J
      – PersonEntity:
          Name:
            NameFull: Sabanathan D
      – PersonEntity:
          Name:
            NameFull: Burstein HJ
      – PersonEntity:
          Name:
            NameFull: Nowecki ZI
      – PersonEntity:
          Name:
            NameFull: Pristauz-Telsnigg G
      – PersonEntity:
          Name:
            NameFull: Brufsky A
      – PersonEntity:
          Name:
            NameFull: Bellet-Ezquerra M
      – PersonEntity:
          Name:
            NameFull: Foukakis T
      – PersonEntity:
          Name:
            NameFull: Novik Y
      – PersonEntity:
          Name:
            NameFull: Rubovszky G
      – PersonEntity:
          Name:
            NameFull: Singer CF
      – PersonEntity:
          Name:
            NameFull: Muehlbacher K
      – PersonEntity:
          Name:
            NameFull: Filho OM
      – PersonEntity:
          Name:
            NameFull: Goulioti T
      – PersonEntity:
          Name:
            NameFull: Law E
      – PersonEntity:
          Name:
            NameFull: Partridge AH
      – PersonEntity:
          Name:
            NameFull: Carey LA
      – PersonEntity:
          Name:
            NameFull: Zoroufy A
      – PersonEntity:
          Name:
            NameFull: Hlauschek D
      – PersonEntity:
          Name:
            NameFull: Fesl C
      – PersonEntity:
          Name:
            NameFull: Mayer EL
      – PersonEntity:
          Name:
            NameFull: Gnant M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 211
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1